”The path from academic research to precision diagnostics in routine health care” Stratipath co-founder is writing an article about Stratipath and the research behind in ”Oncology Sweden”. (Swedish only) – Stratipath

”The path from academic research to precision diagnostics in routine health care” Stratipath co-founder is writing an article about Stratipath and the research behind in ”Oncology Sweden”. (Swedish only)

September 26, 2022

Read the article (Swedish only)

MORE NEWS:

Stratipath And Proscia Announce Partnership, Paving The Way To Bring Relapse Risk Prediction To More Breast Cancer Patients

Stratipath secures its position on the esteemed startup list for the second consecutive year.

Stratipath co-founders, Mattias Rantalainen and Johan Hartman are receiving the prestigious Karolinska Institutet’s award for innovation and utilisation.

”AI can be a game-changer” An exclusive interview featuring Stratipath co-founder Johan Hartman in the Swedish wellness magazine ”Må Bra”

Press releases:

Stratipath And Proscia Announce Partnership, Paving The Way To Bring Relapse Risk Prediction To More Breast Cancer Patients

Professor Jonas Bergh, will be leading our scientific advisory board

The Swedish deep-tech company Stratipath announces its integration with Sectra, one of the most expanding PACS systems for digital pathology

Government grant to provide more accurate breast cancer diagnosis

IN THE MEDIA:

”AI can be a game-changer” An exclusive interview featuring Stratipath co-founder Johan Hartman in the Swedish wellness magazine ”Må Bra”

Stratipath has been recognized as one of the innovative healthcare startups hailing from Stockholm.

Stratipath co-founder Mattias Rantalainen is featured in this article by Healthcareineurope.com

”The path from academic research to precision diagnostics in routine health care” Stratipath co-founder is writing an article about Stratipath and the research behind in ”Oncology Sweden”. (Swedish only)